Research Article
The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population
Table 2
Summary of clinical characteristics of AERD, ATA, and HCS.
| | AERD | ATA | HCS |
| Subjects | 78 | 135 | 134 | Gender (male/female) | 31/47 | 49/86 | 79/55 | Mean age (years, SD) | 42.0 (14.4) | 36.7 (17) | 24 (8.9) | Premethacholine challenge FEV1 (%) | 99.6 (17.3) | 101.4 (12.9) | 98.2 (13.3) | Postmethacholine challenge FEV1 (%) | 75.1 (13.8) | 76.9 (14.4) | 95.4 (11.6) | Pre-L-ASA challenge nasal flow (mL/sec) | 640.75 (162.2) | 689 (178.2) | 670.2 (167.5) | Post-L-ASA challenge nasal flow (mL/sec) | 488 (142.8) | 658.5 (186.3) | 682.4 (165.7) |
|
|
AERD: Aspirin-exacerbated respiratory disease, ATA: Aspirin-tolerant asthma, HCS: Healthy control subjects, SD: Standard deviation, FEV1: Forced expiratory volume in one second, L-ASA: Lysine aspirin.
|